MUNYMEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MUNYMEDICAL
Largest movements
- Current investments +€220,937
new in 2025: €220,937
- Cash -€130,250
down €130,250 (-73.7%), from €176,785 to €46,536
mainly Current investments (-€220,937) and Tax, wage and social debts (-€14,402)
- Deferred charges and accrued income -€5,446
down €5,446 (-54.1%), from €10,063 to €4,617
- Tangible fixed assets +€5,300
up €5,300 (+502%), from €1,056 to €6,356
- Reserves +€105,166
up €105,166 (+71.0%), from €148,076 to €253,242
- Tax, wage and social debts -€14,402
down €14,402 (-59.3%), from €24,275 to €9,874
- Gross operating margin -€59,851
down €59,851 (-27.4%), from €218,792 to €158,941
- Taxes -€20,482
down €20,482 (-29.1%), from €70,275 to €49,794
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €187,904 | €278,446 | +€90,542 | +48.2% |
| Fixed assets | 21/28 | €1,056 | €6,356 | +€5,300 | +502% |
| Tangible fixed assets | 22/27 | €1,056 | €6,356 | +€5,300 | +502% |
| Furniture and vehicles | 24 | €1,056 | €6,356 | +€5,300 | +502% |
| Current assets | 29/58 | €186,848 | €272,090 | +€85,242 | +45.6% |
| Current investments | 50/53 | - | €220,937 | +€220,937 | |
| Cash at bank and in hand | 54/58 | €176,785 | €46,536 | -€130,250 | -73.7% |
| Deferred charges and accrued income | 490/1 | €10,063 | €4,617 | -€5,446 | -54.1% |
| Total equity and liabilities | 10/49 | €187,904 | €278,446 | +€90,542 | +48.2% |
| Equity | 10/15 | €158,076 | €263,242 | +€105,166 | +66.5% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Reserves | 13 | €148,076 | €253,242 | +€105,166 | +71.0% |
| Distributable reserves | 133 | €148,076 | €253,242 | +€105,166 | +71.0% |
| Amounts payable | 17/49 | €29,829 | €15,204 | -€14,625 | -49.0% |
| Amounts payable within one year | 42/48 | €29,485 | €15,204 | -€14,281 | -48.4% |
| Trade debts | 44 | €1,445 | €1,488 | +€43 | +3.0% |
| Suppliers | 440/4 | €1,445 | €1,488 | +€43 | +3.0% |
| Taxes, remuneration and social security | 45 | €24,275 | €9,874 | -€14,402 | -59.3% |
| Taxes | 450/3 | €24,275 | €9,874 | -€14,402 | -59.3% |
| Other amounts payable | 47/48 | €3,765 | €3,842 | +€78 | +2.1% |
| Accrued charges and deferred income | 492/3 | €344 | - | -€344 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €528 | €1,265 | +€737 | +140% |
| Other operating charges | 640/8 | €338 | €1,536 | +€1,198 | +355% |
| Gross operating margin | 9900 | €218,792 | €158,941 | -€59,851 | -27.4% |
| Operating profit (loss) | 9901 | €217,927 | €156,140 | -€61,787 | -28.4% |
| Financial income | 75/76B | €554 | €362 | -€192 | -34.6% |
| Recurring financial income | 75 | €554 | €362 | -€192 | -34.6% |
| Financial charges | 65/66B | €130 | €1,542 | +€1,413 | +1,088% |
| Recurring financial charges | 65 | €130 | €1,542 | +€1,413 | +1,088% |
| Profit (loss) for the period before taxes | 9903 | €218,351 | €154,960 | -€63,391 | -29.0% |
| Income taxes | 67/77 | €70,275 | €49,794 | -€20,482 | -29.1% |
| Profit (loss) for the period | 9904 | €148,076 | €105,166 | -€42,909 | -29.0% |
| Profit (loss) for the period to be appropriated | 9905 | €148,076 | €105,166 | -€42,909 | -29.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.